Clinical Research and Treatment of
Interstitial Cystitis/ Bladder Pain Syndrome

IC Study

Clinical Research to Help Patients with Interstitial Cystitis

Philip C. Bosch, MD
Urologist    (760) 743-0532
651 E. Pennsylvania Ave. Ste 201
Escondido, CA 92025


Urology Residency:  University of California, Irvine (UCI)

  1983-1987                                                   Irvine, CA

General Surgery Residency:  University of Michigan

   1982-1983                                                  Ann Arbor, MI

General Surgery Internship:  Huntington Hospital/ USC Medical Center

   1981-1982                                                   Pasadena, CA/ Los Angeles, CA  

Medical School:  State University of New York, Upstate Medial Center

   1977-1981                                                   Syracuse, NY   

Undergraduate College:  Hope Collage

   1973-1977                                                    Holland, MI   


  • Bosch P et al:  Secondary carcinoma of the penis.  J Urol 1984; 132: 990.
  • Bosch P et al:  Preliminary observations of the results of combined temporary iridium implantation and external beam irradiation for carcinoma of the prostate.  J Urol 1986; 135: 722.
  • Bosch P: A randomized, double-blind, placebo controlled trial of adalimumab in the treatment of interstitial cystitis/bladder pain syndrome. J Urol 2014; 191: 77.
  • Bosch P et al: Treating interstitial cystitis/ bladder pain syndrome as a chronic disease. Rev Urol 2014: 16(2): 83.
  • Bosch P: Examination of the significant placebo effect in the treatment of interstitial cystitis/ bladder pain syndrome. Urology 2014; 84: 321.


Research Experience:

  • Preliminary Observations of the Results of Combined Temporary Iridium Implantation and External Beam Irradiation for Carcinoma of the Prostate
  • Prospective Observational Registry and Patient Survey of the Management of Men with Symptomatic Benign Prostatic Hyperplasia (BPH)
  • Prospective Observational Registry of the Management of Men with Prostate Cancer and Rising PSA Following Definitive Surgical or Radiological Treatment of the Primary Tumor
  • An Investigator Initiated, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of Humira® (adalimumab) For The Treatment of Interstitial Cystitis(IC)
  • Examination of the Significant Placebo Effect in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome
  • A Multicenter, Randomized, Double-blind, Placebo-controlled Study, Evaluating Safety and Efficacy of LiRIS 400 mg in Females with Interstitial Cystitis/Bladder Pain Syndrome- Current
  •  A Phase 2a, Biphasic Adaptive Design Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared with the Individual Components Lidocaine and Heparin in Subjects with Interstitial Cystitis/Bladder Pain Syndrome- Current
  • Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis- Current
  • Development of a Patient-Reported Outcomes Measure for Interstitial Cystitis Impacts/Bladder Pain Syndrome- Current
  • Evaluation of Urinary Cations in Patients with Interstitial Cystitis- Current
  • Evaluation of Urinary Tumor Necrosis Factor- Alpha in Patients with Interstitial Cystitis- Current
  • Evaluation and Treatment of Men with Idiopathic Orchialgia- Current